BioSpace News Archive

Business

Acerus To Report Q1-2022 Financial Results And Host Investor Call

Acerus Pharmaceuticals Corporation will announce its first quarter 2022 financial and operating results on Tuesday, May 10, 2022 before the market opens.

May 5, 2022
·
1 min read
Business

Avalo Therapeutics First Quarter 2022 Financial Results and Business Updates

Avalo Therapeutics, Inc. (Nasdaq: AVTX), today announced business updates and first quarter 2022 financial results.

May 5, 2022
·
9 min read
Business

Insmed Reports First Quarter 2022 Financial Results and Provides Business Update

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported financial results for the first quarter ended March 31, 2022 and provided a business update.

May 5, 2022
·
25 min read
Urgent Care Centers Market Estimated to Expand at a CAGR of 5.3% during the Forecast [2020-2023]

Rise in the number of older population across the globe is projected to boost the demand for urgent care centers globally.

May 5, 2022
·
9 min read
Polysomnography Devices Market: Increasing prevalence of obesity to drive the market

Albany NY, United States: Polysomnography or sleep study is a diagnostic test for sleep disorders. The polysomnography test records the breathing rate, heart rate, oxygen level in blood, and brain waves.

May 5, 2022
·
5 min read
Genetown

PureTech Announces Share Buyback Program of up to $50 Million

PureTech Health plc announces that its Board of Directors has approved a share buyback program in respect of its ordinary shares of one pence each up to a maximum consideration of $50 million.

May 5, 2022
·
4 min read
Pharnext: The Latest Findings From CMT&Me, a ‘Real-World’ Digital Lifestyle Study on Charcot-Marie-Tooth Diseases (‘CMTs’), to be Presented at the 2022 Peripheral Nerve Society (‘PNS’) Annual Meeting

Pharnext SA announces that new findings from CMT&Me, a ‘real-world’ digital lifestyle study in patients with Charcot-Marie-Tooth diseases, will be presented in three poster presentations at the upcoming Peripheral Nerve Society Annual Meeting.

May 5, 2022
·
3 min read
Business

Zealand Pharma Hosts Conference Call on May 12 at 4 pm CET (10am ET) to Present First Quarter Results for 2022

Zealand Pharma A/S announced that it will host a conference call on May 12, 2022 at 4 pm CET following the announcement of results for the first quarter of 2022.

May 5, 2022
·
3 min read
Drug Development

Bavarian Nordic Reports Omicron Data from Phase 2 Trial of its COVID-19 Booster Vaccine Candidate

Bavarian Nordic A/S announced additional results from its Phase 2 clinical trial of ABNCoV2, a VLP-based, non-adjuvanted COVID-19 vaccine candidate.

May 5, 2022
·
4 min read
Business

AlzeCure Publishes its Interim Report for January – March 2022

AlzeCure Pharma AB announced that its interim report for the period January - March 2022 is now available on the company’s website.

May 5, 2022
·
4 min read